Fidelity, J&J back $27.5M round for U.K. respiratory startup

Damian Garde

The 's Pulmocide has pulled down a $ 27.5 million Series A from a big-name cast of investors, setting out to discover and develop some inhaled drugs for viral and fungal infections.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS